ENTITY

SillaJen Inc (215600 KS)

Analysis

Health Care • South Korea

SillaJen, Inc. provides medical research and development services. The Company researches and develops treatment of cancer based on genetic recombination virus. SillaJen conducts its business in South Korea and the United States.

Refresh

No presentations found

We’ll display presentations we find for SillaJen Inc here

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00